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A majority of the bones of the vertebrate cranial vault and craniofacial complex develop via intramembranous ossification, and are
separated by fibrous sutures that undergo osteogenic differentiation in response to growth stimuli. Craniosynostosis is a common human birth
defect that results from the premature bony fusion within skull sutures, and causes a myriad of complications including mental retardation
and craniofacial anomalies. Synostosis of facial sutures has been reported to cause midfacial hypoplasia in some craniosynostosis cases, but
most studies focus on cranial vault sutures. In this study, we have generated a mouse model of frontonasal suture synostosis and midfacial
hypoplasia through the tissue-specific elimination of the AP-2a transcription factor. We report here the generation AP-2CRE, a frontonasal
process (FNP)- and limb-specific CRE recombinase allele that is directed by human AP-2a promoter and enhancer elements. We used the
AP-2CRE line in combination with the conditional AP-2a line to produce a new frontonasal knockout (FKO) mutant that lacks AP-2a in the
FNP and limbs. FKO mice exhibit shortened snouts and wide-set eyes that become apparent at postnatal day 15. The most prominent defects
in FKO snouts are (1) a lack of growth within the frontonasal sutures, and (2) a reduction in the snout vasculature. Additional defects are
observed in the FKO nasal bones and sutures, the nasal cavity cartilage and bony projections, and the olfactory epithelium. The
characteristics of the FKO mouse model are a unique combination of midfacial growth anomalies, and provide the first evidence that AP-2a
is essential for appropriate postnatal craniofacial morphogenesis.
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Interfrontal boneIntroduction
Postnatal craniofacial outgrowth is a dynamic process
that requires the coordinated development of several tissues
within the vertebrate skull. The craniofacial complex con-
sists of the nasal, premaxillary, and maxillary bones, juxta-
posed with the frontal bones of the cranial vault, as seen in a
dorsal view of the mouse skull (Fig. 1A). Both the facial and
frontal bones are derived from the cranial neural crest
(Couly et al., 1992, 1993; Jiang et al., 2002) and undergo
intramembranous ossification, and as such are separated by
secondary growth sites called sutures. The mesenchyme of0012-1606/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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state called patency, while the edges of the bones are
comprised of nonossified osteoblasts and are called osteo-
genic fronts or bone fronts. Ultimately, the purpose of
patency within the cranial vault sutures is to accommodate
the rapid expansion of the brain that occurs after birth.
Postnatal membrane bone growth is essentially achieved by
the recruitment of suture cells to the osteogenic fronts
followed by their differentiation and mineralization, in
response to signals from the bone fronts themselves, and
the dura mater that overlies the brain (for reviews, see
Opperman, 2000; Ornitz and Marie, 2002). Premature
ossification of these sutures results in a condition called
craniosynostosis, and occurs in approximately 1/2500 live
human births (Wilkie and Morriss-Kay, 2001). Such con-
ditions can cause skull deformities, mental retardation,
blindness, and facial anomalies because brain expansion
continues despite the presence of a defective closed suture.
Fig. 1. Schematic representations of postnatal skull components. (A) Dorsal
view of skull to illustrate relative positions of bones. Abbreviations: nasal
cartilage (NC), nasal bone (N), premaxillary bone (PM), maxillary bone
(M), frontal bone (F), parietal bone (P), frontonasal suture (fns), metopic
suture (ms), coronal suture (cs), and sagittal suture (ss). (B) Cartoons of
coronal sections to illustrate nasal cavity structures. Section 1 is toward
distal tip of snout, and section 2 is more proximal to the fns. Additional
abbreviations: nasal septum (ns), superior nasal conchae (snc), vomeronasal
organ (vno), incisor (i), molar (m). Note: Skull schematic is adapted from
Popesko (1992).
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craniosynostosis syndromes, and include mutations of
FGFR-1 (Pfieffer Syndrome; Muenke et al., 1994), FGFR-
2 (Crouzon and Apert Syndromes; Reardon et al., 1994;
Wilkie et al., 1995), TWIST (Saethre–Chotzen Syndrome; el
Ghouzzi et al., 1997; Howard et al., 1997), and MSX2
(Boston-type Craniosynostosis; Jabs et al., 1993).
Proper postnatal facial morphogenesis also requires pa-
tency of the facial sutures. In some craniosynostosis cases,
premature fusion of facial sutures was reported to inhibit
outgrowth of the craniofacial complex, causing a condition
called midfacial hypoplasia (Cohen, 2000). Despite their
importance, the development of craniofacial sutures is poorly
understood. While growth at the osteogenic fronts of the
facial bones is similar to that of the cranial vault bones, the
facial bones differ in that they overlie the cartilaginous
elements of the facial complex rather than the dura mater.
In addition, as the nasal and premaxillary bones elongate
during the postnatal period, growth at the frontonasal and
frontal–premaxillary suture junctions is characterized by
interdigitation patterns that become more complex over time.A majority of genetic and molecular studies focus on the
cranial sutures (i.e. coronal and sagittal) because they are
usually the most severely affected sites of synostosis in the
syndromes described above. Nonetheless, there are several
genes that are expressed in the craniofacial complex and may
play important roles in facial suture development. For
example, FGFR-2 is expressed in the developing bone fronts
of both cranial vault and facial bones in late embryogenesis
(Iseki et al., 1997). In addition, the expression patterns of
TGF-h family members and Msx2 have been characterized
within the rat frontonasal suture (Adab et al., 2002), and
Msx1 expression was reported in the postnatal mouse
frontonasal suture (Orestes-Cardoso et al., 2001). However,
aberrant expression patterns of these genes and/or associated
signaling processes have not been directly associated with
reduced growth at this suture junction.
Internal to the membrane bones of the facial complex are
the elements of the nasal cavity. In a coronal (or frontal) view,
the nasal cavity is medially bisected by the cartilaginous
septum, schematized for the mouse snout in Fig. 1B. Ventral
to the nasal bones, the superior nasal conchae project into the
cavity, and ultimately give rise to the turbinate bones via
endochondral ossification. The vascular mucosa and adjacent
epithelial layers line the entirety of the nasal cavity: respira-
tory epithelia in the distal snout (not shown), and olfactory
epithelia in proximal regions (Fig. 1B). In the proximal two-
thirds of the cavity, the vomeronasal organ (VNO) is present
at the base of the nasal septum, and functions in the chemo-
sensory behaviors of the mouse (i.e. pheromone responsive-
ness) (Figs. 1B – 2) (Wysocki, 1979). Following
embryogenesis, it is important that the craniofacial membrane
bones and nasal cavity elements develop in a concerted
fashion. Through the study of animal models in which these
processes are disrupted, we can better understand how the
various craniofacial tissues interact for appropriate outgrowth
in the postnatal period. In this study, we have generated a
facial-specific AP-2a mutant that exhibits postnatal nasal
bone and nasal cavity anomalies due to impaired growth
within the frontonasal sutures and a reduction in snout
vasculature.
AP-2a is the founding member of a small family of
transcription factors that are characterized by a C-terminal
‘‘basic helix-span-helix’’ domain required for DNA contact
and dimerization (Mitchell et al., 1987; Williams and Tjian,
1991a,b). It is expressed in several tissues throughout
embryogenesis including the neural tube, neural crest, facial
prominences, and limb bud mesenchyme (Mitchell et al.,
1991). Targeted mutagenesis of AP-2a results in a complex
and lethal phenotype that includes failure of anterior neural
tube closure and severe midfacial hypoplasia (Schorle et al.,
1996; Zhang et al., 1996). Chimeric animals composed of
wild-type and AP-2a-null cells often exhibit cleft lip with
or without cleft palate in the absence of neural tube closure
defects, indicating that AP-2a is required for the proper
growth and/or fusion of tissues derived from the embryonic
frontonasal prominence (FNP) (Nottoli et al., 1998). Inter-
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null/+ colony exhibit a malocclusion due to curvature of the
nasal region, which further supports a role for AP-2a in
FNP development and suggests that craniofacial tissues are
sensitive to reduced levels of the gene (Nottoli et al., 1998).
Face and limb development are mechanistically linked
(Richman and Tickle, 1989), and many genes perform
similar functions in both tissues during embryogenesis
(Schneider et al., 1999). In this respect, AP-2a-null mice
also exhibit loss of the radius in most mutants, and a
percentage of chimeras generated exhibit polydactyly and/
or polysyndactyly (Nottoli et al., 1998; Zhang et al., 1996).
Taken together, the loss-of-function studies illustrate that
functional AP-2a plays important roles in both facial and
limb morphogenesis. However, because of the severity of
the AP-2a-null neural tube and facial phenotypes, and the
variable combinations of face and limb defects that occur in
chimeras, it has been difficult to determine the roles of AP-
2a in these tissues.
We therefore sought to elucidate the functions of AP-2a
in facial and limb development by utilizing the CRE-loxP
system of conditional mutagenesis. The first component of
this system is the conditional allele of AP-2a (Alflox) that
was recently generated in our laboratory (Brewer et al.,
2003). The Alflox allele contains loxP sites that flank
exons 5 and 6, which encode a portion of the helix-span-
helix domain that is essential for AP-2a function. To target
the face and limbs, we report here the generation and
characterization of the second component: a novel trans-
genic line (AP-2CRE) in which CRE recombinase expres-
sion is driven by an FNP- and limb-specific enhancer
element, derived from the human AP-2a gene (Zhang
and Williams, 2003). Crossing Alflox and AP-2CRE lines
of mice results in the elimination of AP-2a from the
embryonic face and limb mesenchyme. These conditional
FKO (FNP knockout) mutants exhibit postnatal facial
shortening that becomes apparent approximately 15 days
after birth, and they do not display overt limb abnormal-
ities. We have characterized the progress of the FKO
phenotypes as the mice mature, and have identified defects
within a subset of facial sutures, as well as the nasal bones,
the snout vasculature, and skeletal elements of the nasal
cavity. Previous studies have indicated that AP-2a is
expressed in the mesenchyme of the embryonic facial
primordia. We report here that this gene is also expressed
in postnatal facial tissues. Therefore, the absence of
functional AP-2a from FKO craniofacial tissues in bothFig. 2. Characterization of AP-2CRE transgene activity in mid-embryogenesis u
transgene that contains the human AP-2a promoter and intron 5 frontonasal prom
assays, AP-2CRE activity begins in the cranial neural crest cells (nc) in the lateral r
in the FNP, mesonephros (m), and is faint the forelimb buds (arrowhead). The arr
activity is strong in both FNP and limb bud mesenchyme. Vascular tissue (v) in the
A majority of distal cells are AP-2CRE positive in sections through the middle regi
is most robust around nasal pits in the center of the face, as seen in a sagittal section
Note: Numbered lines in D and F designate planes of sections in E and G, respectpre- and postnatal periods likely contributes to the ob-
served phenotypes. In conclusion, the combination of
defects found in FKO mice represent a unique mouse
model of midfacial hypoplasia, and this study provides
the first evidence that functional AP-2a is directly required
for appropriate postnatal craniofacial morphogenesis.Materials and methods
Mouse strains and PCR genotyping
The AP-2CRE transgenic construct was made by first
cloning a 200 bp XhoI–NcoI fragment of the human AP-2a
promoter into pBluescript. The NLS Cre (gift from Gail
Martin) was introduced using NcoI and EcoRV restriction
sites. A SV40 poly-A tail was then cloned in downstream of
the NLS CRE using EcoRV and BamHI restriction sites. To
generate AP-2CRE, a 1.8-kb enhancer element from human
AP-2a, spanning the middle of exon 5 through the middle
of exon 6 was introduced downstream of the poly-A tail.
The AP-2CRE plasmid DNA was prepared with the Qiagen
MaxiPrep kit, linearized, and purified for injection at the
Yale University Transgenic Core Facility. AP-2CRE geno-
typing was accomplished by PCR amplification of a 350-bp
fragment spanning the AP-2a promoter and CRE sequen-
ces. Primer sequences were: CRE4 5V-GCG CTA ACC CAG
AGA GTA GCT CC-3Vand CRE5 5V-CGC GAA CAT CTT
CAG GTT CTG CGG G-3V. The generation of the condi-
tional Alflox line will be described elsewhere (Brewer et al.,
2003). The primers Alflox4, 5V-CCC AAA GTG CCT GGG
CTG AAT TGA C-3Vand Alfscsq 5V-GAA TCT AGC TTG
GAG GCT TAT GTC-3V were used for genotyping, and
generate a 490-bp fragment from the wild-type AP-2a
allele, and a 560-bp fragment from the Alflox allele. The
AP-2a-null/+ line was described in Zhang et al. (1996), and
the primers Alpha 3VKO 5V-CGT GTG GCT GTT GGG GTT
GTT GCT GAG GTA C-3V and neo 3VKO 5V-AAC GCA
CGG GTG TTG GGT CGT TTG TTC G-3Vwere used for
genotyping.
Breeding AP-2CRE/AP-2a-null/+ males with Alflox
heterozygous or homozygous females generated the FKO
line of mice. To genotype FKO offspring, DNAwas isolated
from tail biopsies of all pups between P1 and P15 using the
DNeasy kit (Qiagen), and 5 Al was then used in the PCR
reactions. Tail tissue DNA from embryos was directly
prepared in a one-step lysis buffer as described for yolksing the R26R reporter strain. (A) Schematic representation of AP-2CRE
inence (FNP) and limb enhancer elements. In whole-mount h-galactosidase
egions of the head at approximately (B) E9.0. (C) At E9.5, activity is strong
ow indicates the migratory path of cranial neural crest cells. (D) By E10.5,
head and a small portion of the first branchial arch (*) are also positive. (E)
on of the FNP (upper) and forelimb bud (lower). (F) At E12.5, CRE activity
through FNP (G), as well as in the distal regions of fore- and hindlimbs (F).
ively, and fb indicates the forebrain in E (top). Size bars represent 1.0 mm.
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Al was used in PCR reactions. All offspring were genotyped
with primer sets described above for AP-2CRE, AP-2a-null,
and Alflox alleles.
Probe generation and in situ hybridization
To generate the AP-2e6 ISH probe, total RNA was
isolated from microdissected wild-type branchial arch 1
samples using the RNeasy kit (Qiagen). Total RNA, 0.5
Ag, was used to generate first-strand cDNA with the First-
strand Synthesis kit (Amersham). The AP-2e6 ISH fragment
was amplified from the cDNA by PCR, and corresponds to
exon 6 of the mouse AP-2a gene (gi 6755733, nucleotides
954–1087). The primers were AP-2EX6A, 5V-GAG AAG
CCG TCC ACC TAG CC-3Vand AP-2EX6B, 5V-GCA GAT
CTG TTT TGT GGC CAG-3V. The amplified DNA was
directly cloned into the pPCR-II plasmid with the Topo TA
Cloning kit (Invitrogen). Positive clones were identified by
digestion with EcoRI and sequenced at the HHMI Keck
Core Facility at Yale University.
For whole-mount ISH, the AP-2e6 probes were generat-
ed according to Riddle et al. (1993), using 11-digoxigenin
(DIG)-UTP (Roche). For the sense control probe, the AP-
2e6 plasmid was linearized with NotI (New England Biol-
abs-NEB) and transcribed with SP6 RNA polymerase
(NEB). For the antisense probe, the AP-2e6 plasmid was
linearized with BamHI (NEB) and transcribed with T7 RNA
polymerase (Roche). After synthesis, RNA probes were
precipitated and resuspended in 50 Al diethyl pyrocarbonate
(DEPC)-treated water (DEPC, Sigma). Note that the sense
control probe does not detect specific expression at E10.5
(data not shown). The FGFR-2 probe was a generous gift
from J. Rossant, and was generated as previously described
(Ciruna and Rossant, 1999).
Noon on the day of the copulatory plug was considered
to be embryonic day (E) 0.5. For whole-mount ISH,
embryos were taken at E10.5 (AP-2e6) and E17.5
(FGFR-2) and dissected in DEPC-treated, ice-cold phos-
phate-buffered saline (PBS) pH 7.4–7.6. Samples were
fixed overnight in 4% paraformaldehyde (PFA; Sigma) in
DEPC-PBS, and were processed as previously described
(Wilkinson, 1992), with minor modifications. For E10.5
embryos, proteinase K digestion was 15 min, and overnight
hybridization was performed in 1 ml of hybridization
solution to which 2 Al of DIG-labeled AP-2e6 probe was
added. For E17.5 skulls, proteinase K digestion was per-
formed for 45 min, and hybridizations were performed in 1
ml of hybridization solution to which 3 Al of DIG-labeled
FGFR-2 probe was added. Alkaline phosphatase conjugat-
ed antidigoxigenin antibody (Roche) was used at a dilution
of 1:1000 overnight at 4jC and detected with BM Purple
substrate (Roche). The reaction was monitored between 1
and 4 h until the color developed, and the embryos and
skulls were subsequently washed in three changes of PBT.
To intensify the color reaction, specimens were dehydratedand immediately rehydrated through a graded methanol
series in PBT. When necessary, embryos were cleared in
PBT:Glycerol (1:1, Sigma).
Whole-mount b-galactosidase assays
Embryos were harvested and dissected in PBS. To assay
skull and limb samples, the epidermis was removed from the
heads and limbs of E15.5 and E17.5 embryos and all
postnatal specimens. h-galactosidase assays were performed
as previously described (Hogan et al., 1994). Briefly, all
specimens were lightly fixed in 0.25% glutaraldehyde
(Sigma) for 30 min and incubated in Xgal substrate (Den-
ville Scientific) solution for 1–2 h for AP-2CRE/R26R, or
2–4 h for AP-2KI. To avoid the limitation of Xgal pene-
tration, specimens were cut into pieces, stained, and pro-
cessed for paraffin sectioning. Skulls were bisected in the
coronal or sagittal plane to allow for staining of the nasal
cavities, while limbs were cut in the transverse plane.
Skeletal preparation and staining
Skeletal preparations were performed as previously
described with minor modifications (Hogan et al., 1994).
Briefly, samples were fixed and dehydrated in 95%
ethanol for a minimum of 3 days, transferred to alcian
blue for 24 h, rinsed in three changes of 95% ethanol, and
soaked in 95% ethanol overnight. Samples were subse-
quently cleared in 1% potassium hydroxide (KOH) for 30
min to 2 h, and stained in alizarin red for 1–3 h. Samples
were rinsed in 2% KOH until they were clear, transferred
to 20% glycerol in KOH overnight, and stored in glycer-
ol:100% ethanol (1:4).
Tissue preparation and paraffin processing
Embryos between E9.0 and E17.5 were harvested and
fixed overnight in 4% paraformaldehyde (PFA) in PBS at
4jC, rinsed in PBS, dehydrated through a graded ethanol
series in PBS, and cleared in xylene as previously described
(Hogan et al., 1994). For paraffin embedding, Paraplast
(VWR Scientific) was melted at 62jC and samples were
introduced to xylene:Paraplast (1:1) for 30 min, followed by
one change of paraffin for 30 min, and then placed into fresh
paraffin overnight.
Postnatal skulls were either decalcified overnight
(rapidly) with CalEx (Fisher Scientific) according to ma-
nufacturer’s instructions, or slowly with 10% EDTA/0.2%
PFA made in PBS, pH 8.0 (samples were stored at 4jC, and
the solution was changed every 3–4 days for 2–6 weeks).
After either decalcification procedure, samples were rinsed
in running water for 3 h, transferred to 70% ethanol, and
embedded in paraffin in an automated processor.
All paraffin sections were cut on a Microm HM340
microtome: 6 Am for E17.5 through P5 samples, and 8–
10 Am for P10 and P15 specimens. For all procedures, slides
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two changes of xylene, and rehydrated through an ethanol
series to water or PBS depending on the procedure. Hema-
toxylin and eosin (H&E) staining was performed with
working solutions obtained from Poly Scientific according
to manufacturer’s instructions. Alcian blue staining was
performed as previously described (Bancroft and Stevens,
1982) and slides were counterstained with nuclear fast red.
After staining, slides were dehydrated and coverslipped
using Permount (Fisher Scientific).
Plastic embedding, sectioning, and staining
Samples between P10 and P21 were skinned and fixed in
10% neutral buffered formalin for 4 h, washed in PBS, and
transferred to 70% acetone. All subsequent steps were
performed at the Yale University Core Center for Musculo-
skeletal Disorders, according to the rapid embedding meth-
od described in Kacena et al. (2003). Briefly, samples were
transferred into 70% ethanol, dehydrated through graded
ethanol series, and infiltrated with destabilized methyl
methacrylate (Sigma) solution at 4jC under a vacuum for
3 days. Samples were then transferred to catalyzed methyl
methacrylate, and placed at 37jC for 2 days. Glass vials
were removed from heat and stored at  20jC. Blocks were
then trimmed and sanded and 4-Am sections were obtained
with a Leica 2165 Microtome and a tungsten carbide knife,
D-profile. Sections were placed on silane-plus coated slides
(Scientific Device Laboratories) and incubated at 60j over-
night. Slides were then processed though toluidine blue or
Von Kossa staining according to standard procedures
(Recker, 1983).
Proliferation assays
To detect proliferation in skulls, pups were injected
with 100 Ag/g of body weight bromodeoxyuridine
(BrDU, Roche) in sterile PBS (Miller and Nowakowski,
1988). The mice were sacrificed 2 h after injection and
the skulls were fixed overnight in 4% PFA in PBS at
4jC, slowly decalcified, processed through paraffin, and
cut at 6 Am. Slides were processed for the BrDU
detection procedure essentially as described by Morgen-
besser et al. (1995). To detect the BrDU, mouse anti-
BrDU antibody (Roche) diluted 1:100 was used with the
avidin/biotin blocking kit (Vector Laboratories), the
MOM kit (Vector Laboratories), and the DAB kit (Vector
Laboratories), according to manufacturer’s instructions.
For PCNA detection, immunohistochemistry was per-
formed with the mouse NCL-L-PCNA antibody (Vector
Laboratories), in combination with the kits described
above for the BrDU procedure. A 1:100 dilution of the
anti-PCNA antibody was used at 4jC overnight. Control
slides containing no anti-BrDU or anti-PCNA antibody
did not have appreciable levels of background stain (data
not shown).Statistical analyses
P values for measurements and cell counts were calcu-
lated with the Student’s t test of probability. The external
measurements of snout length and interorbital distance were
obtained from 10 wild-type and 6 mutant samples, and the P
value was obtained with the following parameters: two-
sample equal variance and two-tailed distribution. P30 skull
measurements and BrDU cell counts were performed on
equal numbers of samples so paired and two-tailed analyses
were performed.
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AP-2CRE activity is confined to the FNP and distal limb
bud
AP-2a expression in the embryonic FNP and limb bud
mesenchyme is directed, in part, by an element in the fifth
intron of the AP-2a gene that was identified in transgenic
enhancer mapping studies (Zhang and Williams, 2003). We
took advantage of these findings to generate the AP-2CRE
transgene, which is composed of 0.2 kb of the human AP-
2a promoter, encompassing the 5V UTR. The promoter
sequence is fused in frame to the CRE recombinase gene,
which contains a nuclear localization signal (NLS-CRE),
followed by a 1.8-kb fragment of human AP-2a that spans
intron 5 (Fig. 2A). Two independent AP-2CRE transgenic
lines were generated, and the recombinase activities were
characterized by breeding founder males and subsequent
positive male offspring with female R26R reporter mice
(Soriano, 1999). We then analyzed the activation of the
floxed lacZ gene in AP-2CRE/R26R embryos by
performing whole-mount h-galactosidase assays. Offspring
from the two AP-2CRE lines had identical characteristics
(Fig. 2 and data not shown).
AP-2CRE expression begins between E8.75 and E9.0 in
lateral head mesenchyme and migrating cranial neural crest
cells (Fig. 2B). At E9.5, h-galactosidase activity is now
strong in the FNP but it is minimal in the lateral regions of
the head, which reflects the migratory properties of the
cranial neural crest (compare Fig. 2B with Fig. 2C). In
addition, mesonephric tissues are positive at this stage and
activity is just beginning in the limb bud mesenchyme (Fig.
2C). By E10.5, distinct medial and lateral nasal prominences
(MNP and LNP, respectively) have arisen from the FNP, and
expression associated with the head at this stage is strongest
in these MNP and LNP tissues. There is also a small
positive region within the first branchial arch and variable
levels of h-galactosidase activities are present within the
vascular network of the head (Fig. 2D). In sections from
E10.5 samples, most of the mesenchymal cells in the MNP
and LNP are positive, and patchy activity is observed in the
overlying facial ectoderm (Fig. 2E and data not shown).
With respect to the E10.5 limb buds, h-galactosidase
D.K. Nelson, T. Williams / Developmental Biology 267 (2004) 72–9278activity is most robust in the distal mesenchyme, encom-
passing the cells within the presumptive progress zone (Fig.
2E). Note that the domains of AP-2CRE-mediated activity
in the face and limbs represent a specific subset of the
tissues in which the endogenous AP-2a gene is expressed
(Mitchell et al., 1991).
Between E10.5 and E12.5, the craniofacial complex
undergoes several significant changes, including outgrowth
and fusion of the facial prominences. h-galactosidase activ-
ity in E12.5 AP-2CRE/R26R embryos reflects these mor-
phogenetic processes, highlighting how the FNP tissues
give rise to the most central features of the developing face
(Fig. 2F, right) including the area surrounding the nasal pits
and the medial portion of the upper lip. In addition, there is
a small region of positive cells in the ventral maxillary
prominence, but otherwise the AP-2a enhancer element we
used does not drive expression in the branchial arches (Fig.
2F, right; Zhang and Williams, 2003). In the limb bud, h-
galactosidase activity is strongest in the handplate and is
less robust toward the proximal regions of the limbs (Fig.
2F, left). Similar to E10.5 embryos, sections through the
FNP and limb buds at E12.5 show that most of the distal
mesenchyme cells are positive (Fig. 2G and data not
shown). In stages beyond E12.5, h-galactosidase activity
remains confined to the derivatives of the FNP and distal
limb bud mesenchyme (see below; data not shown).
AP-2CRE/R26R marks FNP and distal limb derivatives
To determine the structures to which AP-2CRE-positive
cells ultimately contribute, we utilized the lineage tracing
properties of the R26R line and performed h-galactosidase
assays with AP-2CRE/R26R mice at late embryonic and
postnatal time points. Whole-mount skull preparations be-
tween E15.5 and postnatal day (P) 15 reveal that AP-2CRE
activity marks the precursors of the following tissues: the
nasal bones and nasal sutures, the frontonasal sutures, a
small portion of the frontal bones, and the metopic suture
(Figs. 3A,B). Also, small regions of the premaxillary bones
are positive at P15 (Fig. 3B). In sections obtained from P1
embryos, robust activity is found in the nasal bones and
sutures, the cartilage throughout the nasal cavity, and the
nasal mucosa lining the cavity (Figs. 3C,D). It is noteworthy
that h-galactosidase activity is not found in the posterior
regions of the frontal bones, the frontal-premaxillary
sutures, or within the blood vessels of the nasal cavity.
To address AP-2CRE activity in forelimb derivatives,
whole-mount h-galactosidase assays were performed with a
series of limbs from which the outer tissues were removed
to expose the inner layers of skeletal muscle and bone. AP-
2CRE activity is not found in the ectoderm (Fig. 3) and the
lacZ substrate does not penetrate the epidermis beyond
E15.5 (data not shown) and therefore all whole-mount
samples from later timepoints were stained following re-
moval of the skin. At E17.5 and P1, h-galactosidase activity
was present from the tips of the digits to the middle portionof the skeletal muscle that surrounds the humerus (data not
shown). Similarly, at P5, AP-2CRE/R26R-mediated h-ga-
lactosidase activity was most robust in the distal limb
elements, in both the skeletal muscle and tendons of the
zeugopod (Fig. 3E). Further, limb bones stained after the
removal of the skeletal muscle exhibited robust activity
along the ulna and radius, while patchy activity was
observed in the humerus (data not shown). Next, sections
of AP-2CRE/R26R forelimbs were analyzed for h-galacto-
sidase activity between E15.5 and E17.5. This analysis
demonstrated that the distal mesenchyme cells were uni-
formly targeted by the AP-2CRE transgene, including the
skeletal condensations of the digits, radius, and ulna (Figs.
3F,G) and the skeletal muscle (data not shown). Together,
the data indicate that AP-2CRE-mediated h-galactosidase
activity is greatest within the distal limb derivatives.
AP-2a is successfully eliminated from the developing FNP
and limb buds using AP-2CRE
We next tested the AP-2CRE transgene in the context of
the conditional AP-2a allele (Alflox) (Brewer et al., 2003),
and accomplished this tissue-specific disruption in a two-
step breeding scheme. First, male mice positive for AP-
2CRE were crossed with AP-2a-null/+ females. Males
containing the AP-2CREDAP-2a-null/+ combination were
then bred with Alflox heterozygous or homozygous
females, and the offspring were examined for craniofacial
and/or limb defects. Facial anomalies were only observed in
progeny with the combination of AP-2CREDAlfloxDAP-
2a-null alleles, and are called FKO for ‘‘FNP-Knockout’’
mice.
To confirm the loss of AP-2a from the embryonic FNP
and limb buds in FKO mice, in situ hybridization (ISH) was
performed using a 144-nucleotide RNA probe specific for
the sixth exon (AP-2e6). Exon 6 is present in the wild-type
AP-2a and the nonrecombined Alflox alleles, and it is
absent from the AP-2a null and the recombined Alflox
alleles. Whole-mount ISH with the AP 2e6 probe was
carried out at E10.5 on embryos of all genetic combinations.
In wild-type embryos, the FNP, branchial arches, limb
buds, and the neural tube are all positive for AP 2e6
(Figs. 4A–C). In FKO embryos, AP-2a is not expressed
in the FNP and limb buds, while the neural tube pattern is
similar to that of wild-type littermates (Figs. 4D–F) dem-
onstrating that AP-2a is deleted only from the appropriate
tissues in the FKO combination.
FKO mice exhibit postnatal craniofacial anomalies
FKO embryos examined at E12.5 and E15.5 did not
display any morphological defects (data not shown). Several
litters were allowed to mature, and at weaning we found that
all FKO mice had shortened, more rounded snouts and
subtle interorbital hypertelorism relative to wild-type litter-
mates (see Fig. 5).
Fig. 3. AP-2CRE transgene activity in skull and limb derivatives. Whole-mount h-galactosidase assays of AP-2CRE/R26R positive skulls at P1 (A) and P15
(B) show strong activity is present in nasal bones (n) and suture, the nasal cartilage (nc), the frontonasal suture (arrowheads), and the metopic suture (ms). In
serial sections at P1 (at the level of the arrow in A), AP-2CRE mediated h-galactosidase activity is robust in (C) the nasal bones and suture (ns), and (D) the
septal cartilage (sc), and nasal cavity mucosa (m). Activity is not present in the olfactory epithelia (oe), or mucosal arteries (a). (E) In skinned P5 limbs, the
distal two-thirds of the zeugopod (z) is positive, including digits (d) and skeletal muscle (sm). (F) Sagittal section through the handplate at E15.5 to illustrate
AP-2CRE-mediated h-galactosidase activity is present throughout the mesenchyme, including cells that give rise to the skeletal condensations of the digits (d).
Note that the overlying ectoderm (e) lacks h-galactosidase activity. (G) AP-2CRE activity has also targeted the cells giving rise to the radius (r) and ulna (u).
Size bars represent 1.0 mm.
D.K. Nelson, T. Williams / Developmental Biology 267 (2004) 72–92 79Litters were then examined at various postnatal stages
beginning at P1 to determine when facial defects become
apparent. As late as P10, there are no obvious external
differences between wild-type and FKO pups (Fig. 5A). By
P15, FKO mice can be distinguished from wild-type litter-
mates because the tips of their snouts are slightly flattened(data not shown). At P21 and later stages, 100% of mutants
are readily identifiable due to visibly shorter snout lengths
and slightly wide-set eyes (Fig. 5B and data not shown).
External measurements have been obtained from the ears to
the tip of the nose and between the eyes for mice at P30.
The FKO snouts (n = 5) at this time point were approxi-
Fig. 4. AP-2e6 ISH expression patterns at E10.5. (A,D) Frontal view of frontonasal prominence (FNP). (B,E) Lateral view of forelimb (FL). (C,F) Dorsal view
of neural tube (NT). In wild-type (WT) embryos, AP-2e6 expression is present in (A) FNP, (B) FL, and (C) NT. In FKO embryos, expression is absent from (D)
the FNP and (E) FL, but remains in (F) the NT. Note: Intense stain in brain tissues (A,D) is due to trapped probe, and is not specific to AP-2a expression. Size
bar (F) represents 0.5 mm, same scale for A–F.
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11% wider than those of wild-type (n = 10) littermates (P <
0.005 and P < 0.001, respectively). Such differences
correspond to a 1–2 mm difference in each dimension.
Importantly, the overall body lengths from the base of the
tail to the base of the skull were similar between all mice
measured (6.5–7.0 cm), indicating the defects in the FKO
mice are specific to the snout.
Skull preparations reveal nasal bone and suture defects in
FKO snouts
To determine which craniofacial elements are affected in
FKO pups, skull preparations at several late embryonic and
postnatal stages were stained with alcian blue and alizarin
red to visualize cartilage and bone, respectively. From E15.5
through P5, wild-type and FKO skulls show similar patterns
of craniofacial cartilage and bone staining, indicating that
early skeletal development is not impaired in the mutants
(Figs. 5C,D and data not shown). However, by P10, the
FKO nasal bones are visibly shorter than in matched wild-
type samples, and the lengths of the mutant facial skeletons
are slightly reduced (Figs. 5E,F), despite the observation
that the pups do not exhibit obvious external differences
(see Fig. 5A).
As postnatal outgrowth continues, the elements of the
mutant facial skeleton become more severely affected. We
compared wild-type and FKO samples by aligning them at
the coronal sutures, as skull structures caudal to the frontal
bones are neither targeted by AP-2CRE nor affected in FKO
mice. At P15 and later stages, the FKO snouts are obviously
shorter than in wild-type samples and the nasal bones are
truncated, indicating that both bone and cartilage outgrowth
are reduced in the mutants (Figs. 5G,H and data not shown).
P30 skulls (n = 4) were prepared and several differences
were found between the wild-type and FKO nasal regions.
Measurements taken from the coronal suture to the tip of the
nasal cartilage reveal that the mutant snouts are approxi-mately 14% shorter than those of wild-type littermates at
this stage (P < 0.05), and the FKO nasal bones themselves
are approximately 18% shorter (P < 0.05). Of interest, due
to the nasal bone truncation, the distal nasal cartilage
appears longer in FKO samples when compared to wild-
type counterparts (Figs. 5G,H). Furthermore, the mutant
nasal bones are squared at the ends, in contrast to the
tapered wild-type bones (Figs. 5G,H and K,L). In lateral
views of P30 snouts, wild-type samples are convex and the
distal edges of the nasal bones are in line with the distal
edges of the premaxillary bones (Fig. 5I). In contrast, the
FKO samples tend to be concave, and it is clear that mutant
premaxillary bones extend beyond the distal edges of the
nasal bones (Fig. 5J). This altered arrangement of the FKO
facial bones results in an anterior shift of the upper incisors
toward the distal nasal cartilage, as compared to wild-type
samples (Figs. 5I,J). Further examination of the skeletal
preparations revealed that in addition to the nasal bone
defects, the FKO frontal bones are approximately 13%
shorter (P < 0.05) and the FKO interorbital distances are
approximately 5% wider (P = 0.05) than those of wild-type
littermates (Figs. 5G,H and data not shown). The nasal and
frontal bones approximate between the orbits at the fronto-
nasal sutures, and two major defects are apparent in this
junction in mutant skull preparations. First, the mutant
frontonasal sutures are displaced posteriorly with respect
to the frontal–premaxillary sutures (Figs. 5K,L). Second,
the FKO frontonasal sutures do not exhibit the extensive
interdigitation patterns observed in wild-type littermates. It
is important to note that both wild-type and FKO frontal-
premaxillary sutures, structures that are not targeted by AP-
2CRE, have similar degrees of interdigitation (Figs. 5K,L,
asterisk).
Finally, another defect we observed in FKO mice was the
presence of ectopic bone within the metopic sutures, called
interfrontal (IF) bone. One hundred percent (n = 20) of late
embryonic and early postnatal FKO skull preparations
exhibited some degree of IF bone, ranging from a small
Fig. 5. Postnatal craniofacial defects in FKO mice. (A) At P10, wild-type (WT; left) and mutant (FKO; right) pups have similar external facial morphologies.
(B) At P40, FKO mice (right) exhibit shortened snouts and interorbital hypertelorism. (C–N) Skeletal preparations stained with alcian blue (blue) and alizarin
red (red) to visualize cartilage and bone, respectively. (C,D) At P1, WT FKO snouts are similar in size and shape. (E,F) At P10, snout and nasal bones from a
WT are slightly longer than in an FKO mutant. (G,H) At P30, the FKO snout is approximately 2 mm shorter than wild type. Lateral views of P30 snouts show
that in a WT sample (I), the distal edges of the nasal and premaxillary bones are in line (arrowhead). In contrast, (J) the distal edge of the FKO nasal bone (white
arrowhead) is visibly shorter than that of the premaxillary bone (yellow arrowhead). (K) WT frontonasal (arrowhead) and frontal–premaxillary (*) sutures are
interdigitated. In contrast, the FKO frontonasal sutures (L) lack interdigitation, but the frontal–premaxillary suture is similar to WT. (M) WT and (N) FKO
limbs are similar. Abbreviations: frontal bone (f), premaxillary bone (pm), nasal bone (n), nasal cartilage (nc), incisor (in). Arrows in panels D, F, and L mark
the interfrontal bone. Size bars (C–N) represent 1.0 mm.
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of the frontal bones (Figs. 5D,F; also see Fig. 9B). Note that
IF bone was also found in 44% (n= 60) of the skulls of all
other genetic combinations that resulted from our breeding
scheme, including embryos that did not contain any of the
genetically manipulated AP-2a alleles (data not shown).
Thus, the deletion of AP-2a in the FKO mice significantly
increases the incidence of IF bone.
FKO forelimbs do not have obvious defects
AP-2a is expressed in the progress zone of the limb
bud, and the forelimbs of mice lacking AP-2a frequently
show defects in the zeugopod or autopod (Nottoli et al.,
1998; Zhang et al., 1996). To determine if the loss of AP-
2a from the distal limb mesenchyme in FKO mutants
affected limb morphology, wild-type and FKO limbs were
prepared and stained to visualize bone and cartilage. Unlike
the distal forelimb defects found in previous AP-2a mutant
studies, no obvious morphological differences were ob-
served in the mutant fore- or hindlimbs at any of the
embryonic or postnatal stages examined (Figs. 5M,N and
data not shown).
Loss of AP-2a from the embryonic FNP results in
frontonasal suture defects
Histological analyses were performed in sectioned
materials to determine the extent to which the nasal and
frontal bones, and the associated frontonasal sutures, were
affected in the FKO snouts. Decalcified, paraffin-embed-
ded samples were stained with hematoxylin and eosin
(H&E) for structural analyses. Within the frontonasal
suture junction, the nasal and frontal bone fronts overlap
extensively, as seen in a schematized sagittal section (Fig.
6A). In addition, undifferentiated mesenchyme lies be-
tween the bone fronts, and immature, nonmineralized
osteoblasts (called osteoid) are present at the edges of
the bones. In sagittal sections obtained at the level of the
frontonasal sutures, there are no obvious morphological
differences between wild-type and FKO samples before
P15 (data not shown). In H&E stained sections at P15, we
observe that the frontonasal sutures of wild-type and FKO
samples are generally of similar size and shape (Figs.
6B,C). However, upon close examination of the FKO,
nasal bone fronts are often thinner in the proximal–distal
axis than in matched wild-type sections, which becomes
apparent by comparing the distances between (1) the
proximal edges of the nasal bone fronts and (2) the nasal
bone marrow (Figs. 6BV,CV). To examine this phenomenon
in greater detail, nondecalcified snouts were embedded in
methyl methacrylate (plastic) and subjected to toluidine
blue or Von Kossa staining to visualize bone structure and
determine the extent of mineralization in the samples. In
wild-type plastic sections at P15, toluidine blue and von
Kossa staining illustrate that the nasal bone front is alargely nonossified osteoid projection that forms a poste-
rior extension of the mineralized matrix of the nasal bone
proper (Figs. 6DV,F). Matched FKO sections reveal that the
overall length of the nasal bone front is similar to that of a
wild type, as described above in the paraffin-processed
samples. However, the relative contribution of osteoid to
this bone front extension in the FKO mutant is much
reduced compared to a wild-type sample, and there is a
corresponding increase in the mineralized portion (Figs.
6EV,G). These data indicate that the osteoblasts in the
mutant nasal bone fronts may prematurely differentiate,
which would lead to inappropriate secretion of mineralized
matrix and perturbation of postnatal sutural growth.
FKO snouts exhibit nasal bone, nasal suture, and cartilage
anomalies
To further investigate the FKO snout anomalies, coronal
sections of plastic- and paraffin-embedded samples were
examined. At P5, the initial defect observed is an increase
in FKO nasal bone thickness (data not shown). As the
mutants mature, nasal bone and suture anomalies become
more severe and are best illustrated at P15. In the
dorsoventral axis, wild-type nasal bones are thick in the
midline and become thinner in the lateral regions of the
bones, as seen in plastic (Fig. 7A) and paraffin (Figs.
7C,E) sections of P15 samples. The nasal sutures define
the midlines of the sections and are aligned with the nasal
septum (Figs. 7A,C,E). In contrast, the FKO nasal bones
display an increased thickness in the dorsoventral axis
within the lateral portion of the bones (Figs. 7B,D), and
the nasal sutures are wider in the mediolateral axis (Fig.
7BV), when compared to wild-type samples. In addition, the
mutant nasal sutures are slightly off-center and are often
laterally angled with respect to the nasal septum (Fig.
7BV,D,F).
Within the nasal cavities, defects in FKO samples are
not apparent at P5, are subtle at P10, and more pronounced
by P15 (Fig. 7 and data not shown). In P15 wild-type
sections obtained 2 mm from the distal tip of the snout, the
dorsal portion of the nasal septum contains a triangular
patch of cartilage that is intensely stained with toluidine
blue, typical of chondrocytes in the proliferative stage of
development (Figs. 7A,AV). By 2.5 mm, this septal cartilage
has formed a distinct ‘‘Y’’ shape (Fig. 7C). In contrast, the
septal cartilage of matched FKO snout sections obtained
from the distal halves of the nasal bones contains regions of
discontinuity (Figs. 7B,BV,D). Of interest, the unstained
regions of the mutant septa contain cells that resemble
immature chondrocytes, which may indicate that matrix
secretion is impaired in the mutant samples. It is also
important to note that the distal tip of the nasal cartilage,
which protrudes from the nasal bones, is similar in mor-
phology and composition in wild-type and FKO samples
(data not shown). With respect to the superior nasal
conchae, the wild-type projections have an ‘‘S’’ shape in
Fig. 6. Examination of the frontonasal sutures of wild-type and FKO snouts at P15. (A) Schematic representation of the frontonasal suture in the sagittal plane.
The frontal (f) and nasal (n) bone fronts overlap, and are separated by undifferentiated suture mesenchyme (s). Immature osteoblasts (o) line the bone surfaces
at the interfaces with the suture cells. (B–CV) Paraffin sections stained with hematoxylin and eosin (H&E). (B,C) 10 magnification. (BV,CV) 25 (BV) WT and
(CV) FKO images, corresponding to boxed regions in B and C, respectively. Note that the (CV) FKO nasal bone front, lined at the proximal surface, is thinner than
in the (BV) wild-type sample (double-headed arrows). The nasal bone marrow is indicated with an asterisk (*). (D–G) Plastic sections stained with (D–EV)
toluidine blue or (F,G) Von Kossa. (D,E) 10 magnification. (DV–G) 25 (DV,F) WT and (EV,G) FKO images, corresponding to boxed regions in D and E,
respectively. Black arrowheads in DV–G mark the proximal limits of the unmineralized nasal bone fronts. Blue arrowheads in E and F mark the proximal limits
of the mineralized matrix within the nasal bones. Abbreviations: frontal bone (f), nasal bone (n), suture (s), wild-type (WT). Size bars in D and DVrepresent 0.1
mm for 10 and 25 panels, respectively.
D.K. Nelson, T. Williams / Developmental Biology 267 (2004) 72–92 83more distal regions of the snout, while the FKO counter-
parts are reduced and misshapen (Figs. 7C,D). Interestingly,
the septal cartilage and bony projections in more proximal
regions of the snout are quite similar to those of wild-type
samples (Figs. 7E,F). Together, the data illustrate that the
FKO nasal cavity cartilage and bone abnormalities worsen
as the mice mature, and are confined to regions underlying
the distal halves of the nasal bones.FKO snouts exhibit reduced FGFR-2 expression levels and
proliferation defects
The phenotypes within FKO nasal bones and sutures
become apparent between P10 and P21 and appear to be
due to a growth defect. Previous studies have shown that
late in normal embryogenesis, the edges of the bone fronts
within the developing skull express FGFR-2, and are a
proliferative cell population, as evidenced by bromodeox-
Fig. 7. Coronal section analyses of wild-type and FKO snout samples. (A–BV) Plastic coronal sections stained with toluidine blue. (A,B) 10 plastic sections 2
mm from the distal tip of the snout. (A) Wild-type (WT) and (B) FKO sections are bisected by the nasal septum (ns) and contain projections from the superior
nasal conchae (snc). (A) WT nasal bones are thickened at the level of the nasal septum and are tapered laterally; septal cartilage (c) is present ventral to the
nasal bones. The (B) FKO nasal bones are more uniform in thickness in the dorsal–ventral axis and the cartilage contains regions of discontinuity in the
toluidine blue stain. (AV,BV) 25 plastic sections show disorganization of nasal suture (arrowhead) and the discontinuity of the cartilage is apparent (*) in (BV)
FKO samples as compared to (AV) WT. (C–F) Paraffin sections stained with alcian blue, counterstained with nuclear fast red. The (D,F) FKO nasal suture (red
arrowhead) is disorganized as compared to (C,E) WT. In the distal snout, (D) FKO septal cartilage contains discontinuous regions (*) and the superior nasal
conchae projections are misshapen (red arrow) compared to (C) WT. In more proximal regions of snout, (E) WT and (F) FKO samples have similar septal
cartilage structures, and the (F) FKO conchae projections are slightly misshapen. Size bars represent 0.1 mm.
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To determine if growth differences exist between wild-type
and FKO frontal and nasal bones before the manifestation
of the mutant anomalies, we performed FGFR-2 ISH and
BrDU assays. Ten pairs of skulls were processed for
whole-mount FGFR-2 ISH. At E17.5, the bone fronts of
both wild-type and FKO parietal and interparietal bones
have similar levels of FGFR-2 expression (data not
shown). With respect to the frontal bones, wild-type
samples exhibit diffuse expression along the medial surfa-ces, and have slightly stronger expression in the bone
fronts adjacent to the facial sutures (data not shown). In
the nasal regions, nasal bones exhibit strong perimeter
expression, and the entire surfaces of the premaxillary
bones express FGFR-2 (Fig. 8A). Mutant littermates ex-
hibit a range of FGFR-2 expression patterns in the devel-
oping facial complex. Approximately 50% of the FKO
nasal bones have perimeter staining patterns similar to
wild-type littermates, but the levels are slightly reduced
(data not shown). Other mutants exhibit obvious reductions
Fig. 8. FGFR-2 and PCNA expression studies. (A,B) Whole-mount FGFR-2 ISH at E17.5. (A) Wild-type (WT) nasal (red arrows) and frontal (arrowheads)
bone fronts show strong FGFR-2 expression. (B) In contrast, the FKO snout exhibits reduced expression in both nasal and frontal bone fronts. (C,D) PCNA
expression at P15. (C) WT samples contain PCNA-positive (brown) nuclei throughout the nasal bone front adjacent to the frontonasal suture (double-headed
arrow). (F) FKO frontonasal sutures contain positive cells within the interface between the suture mesenchyme and the nasal bone fronts (arrows). The nasal
bone fronts (*) of mutant samples are largely PCNA-negative. Abbreviations: nasal bone (n) and frontal bone (f). Size bar in B represents 1.0 mm. Size bar in D
represents 0.1 mm.
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distal regions of the nasal bones (Fig. 8B), as well as a
decrease in the suture-associated expression in the frontal
bones. In addition, mutants with more obvious reductions
in nasal bone expression often have less premaxillary bone
staining (Fig. 8B).
BrDU studies were subsequently carried out at P1, and
cell counts were obtained from the nasal and frontonasal
sutures as well as within the nasal septum. Growth rates
were similar between wild-type and FKO samples in both
the nasal and frontonasal sutures. In contrast, in the nasal
septum approximately 5% of the cells were proliferating in
wild-type samples, while approximately 2.7% were prolif-
erating in the matched FKO sections (n = 3, P < 0.005).
This finding may partially explain the septal cartilage
defects we observe in the FKO snouts. We next examined
BrDU incorporation in the frontonasal sutures in P5 and P15
sagittal sections, but there were no significant differences
between wild-type and mutant samples at either stage (data
not shown). At P15, the BrDU labeling index was less than
1% for both wild-type and mutant samples. Therefore, we
examined the expression of the proliferation marker PCNA
at this stage. In the frontonasal sutures, wild-type and FKO
samples exhibit PCNA expression within the suture mesen-
chyme adjacent to both the nasal and frontal bones (Figs.
8C,D). In most sections examined from wild-type samples,
most of the cells within the nasal bone fronts are also
positive for PCNA (Fig. 8C). In contrast, sections from
the nasal bone fronts of the FKO samples tend to contain aridge of PCNA-positive cells adjacent to the suture cells,
while the remaining cells of the bone front are negative (Fig.
8D). Of interest, apoptosis was also investigated at P1, P5,
and P15, and no aberrant cell death occurs in the FKO
samples at these stages (data not shown). Taken together,
these data suggest that slight reductions in early growth
factor signaling and perturbed postnatal cell proliferation are
involved in the defects observed in the FKO snouts, rather
than inappropriate cell death.
Loss of AP-2a from the FNP results in vascular defects
In addition to the overt bone anomalies identified in FKO
skull preparations, we observed vascular reductions within
the mutant nasal bones as early as P15 (data not shown). At
P30, wild-type nasal bones have a characteristic vascular
pattern that extends from the frontonasal suture to the
middle portion of the bones. In addition, a thin line of
vessels extends toward the distal edges of each of the nasal
bones at the facial midline (Fig. 9AV). In contrast, FKO
samples often have a less regular vascular network adjacent
to the frontonasal sutures, which does not reach the middle
region of the nasal bones, and the midline extensions are
small or absent (Fig. 9BVand data not shown). In the FKO
snout pictured in Fig. 9B, blood vessels are visible in the
distal regions of the nasal bones, but two other mutant
samples analyzed were devoid of vasculature in this region
(data not shown). Importantly, wild-type and FKO frontal
bones have similar vascular patterns (Figs. 9A,B), indicating
Fig. 9. Vascular anomalies in FKO pups. (A,B) Nasal bone vascular patterns in whole-mount preparations at P30. (A) Wild-type (WT) skull. (AV) WT nasal
bones. Note that the blood vessel network within the proximal two-thirds, and the thin extensions in the midline of the distal third of the snout. (B) FKO skull.
(BV) FKO nasal bones. The vascular network is reduced and disorganized compared to (AV). Arrowheads mark the distal limits of the nasal bone vascular
networks associated with the frontonasal sutures. The bracket in B delimits the interfrontal bone. (C–J) Paraffin sections stained with H&E to visualize nasal
cavity structures at P15. Note: C, D are distal to, and E, F are proximal to the frontonasal sutures. (C–F) are 10 , (CV–FV, G–J) are 25 , and CV–FVcorrespond
to the regions indicated with arrows in C–F. At P15, the (D,F) FKO mucosa (*) and olfactory epithelia (oe) are thinner than in (C,E) WT samples. The VNO
vessels (thin arrows) are also reduced in (I,J) FKO samples, as compared to (G,H) WT littermates. Size bars in A and B represent 1.0 mm. Size bars in E and G
represent 0.1 mm for 10 and 25 panels, respectively.
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the mutant samples.
In paraffin sections, differences are not apparent between
wild-type and mutant samples from E13.5 through P5 (data
not shown). However, we found that among the eight pairs ofwild-type and mutant snouts sectioned between P10 and P15,
approximately 50% of the FKO samples exhibit a noticeably
reduced thickness of the mucosa that specifically underlies
the nasal bones (Figs. 9C–FVand data not shown). Discerning
individual veins and arteries within the mucosal mesenchyme
Fig. 10. AP-2a is expressed in late embryonic and postnatal skull tissues. (A) AP-2KI-associated h-galactosidase activity is present in the nasal bone (n),
frontonasal suture (arrowheads), and metopic suture (ms) at E17.5. (B,C) In sections, additional expression is visible in (B) the nasal suture (ns). (C) In the
region of the nasal septum, the septal cartilage (sc), mucosal mesenchyme (m), and arteries (a) are positive. (D) At P5, expression persists in the nasal bones,
the frontonasal and metopic sutures, and expression is strong in the frontal–premaxillary sutures (fps). (E) AP-2KI-negative P5 sample illustrates background
staining in frontal, nasal, and premaxillary bones. Size bars represent 1.0 mm.
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thinner regions of the mutant mucosa, accompanied by
reductions in the thickness of the adjacent olfactory epithelia
(Figs. 9DV,FV). In addition, we found that the large vessels
associated with the vomeronasal organ (VNO) are reduced in
all FKOmice when compared to wild-type littermates (Fig. 9,
compare littermates G,I and H,J).
VEGF and VEGFR-2 are essential for vascular develop-
ment, and studies have demonstrated that they are transcrip-
tional targets of AP-2a (Gille et al., 1997; Papetti and
Herman, 2002; Ronicke et al., 1996). Therefore, we per-
formed immunohistochemistry for VEGF and VEGFR-2 in
wild-type and mutant samples at several stages between
E15.5 and P15, but observed no apparent differences
between the expression of these molecules at any of the
stages examined (data not shown). From these results AP-
2a is clearly not affecting the vasculature by a direct affect
on VEGF and VEGFR-2 expression levels, although we
cannot exclude the possibility that post-translational
changes in VEGF activation may still occur during pathol-
ogy (Colnot et al., 2003).
Postnatal AP-2a expression in the craniofacial complex
correlates with AP-2CRE activity
Analyses of the FKO phenotypes suggested two basic
possibilities with respect to the roles of AP-2a in facial
development. First, loss of AP-2a from the embryonicFig. 11. Correlation of AP-2a expression and AP-2CRE/R26R h-
galactosidase activities. Alignments of whole-mount skull preparations to
compare (A) AP-2KI- and (B) AP-2CRE-dependent h-galactosidase
activities with (C) WT and (D) FKO suture interdigitation patterns. (A–
D) Arrowheads indicate the frontonasal sutures, which are positive for (A)
AP-2a and (B) AP-2CRE. (A,B) Arrows indicate the frontal–premaxillary
sutures, which express AP-2a, but do not contain AP-2CRE activity. (C,D)
Asterisks (*) mark the frontal–premaxillary suture interdigitation patterns.
In sections, (E) AP-2a and (F) AP-2CRE are present in the septum and
mucosa. The blood vessels (red arrows) within the mucosa express (E) AP-
2a but do not possess (F) AP-2CRE activity.FNP, a tissue in which the gene is expressed, may be
sufficient to hinder proper postnatal growth. Second, if AP-
2a is expressed in postnatal facial structures, loss of the gene
from the derivatives affected by AP-2CRE might be detri-
mental to snout outgrowth. Therefore, we have characterized
AP-2a expression at late embryonic and early postnatal
stages in the craniofacial complex using the AP-2KI line of
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introduced into the AP-2a locus, and h-galactosidase activity
recapitulates endogenous AP-2a expression in heterozygous
animals. AP-2a expression is described below for skull
preparations from various stages, and compared to the
aforementioned AP-2CRE/R26R h-galactosidase activities
(Fig. 2). Importantly, the structures in common are tissues
that lack functional AP-2a in FKO mutant mice.
In whole-mount preparations at E15.5 and E17.5, AP-2KI-
associated h-galactosidase activity is detected in the nasal
regions of the embryos and is weak in the anterior portion of
the metopic sutures (Fig. 10A and data not shown). In serial
sections at E15.5 and E17.5, AP-2a is expressed in the nasal
bones and sutures as well as in the mucosal mesenchyme and
associated blood vessels (Figs. 10B,C and data not shown). In
addition, nasal septal cartilage and the primordia of the
superior nasal conchae exhibit weak expression at E15.5 that
is less intense by E17.5 (data not shown).
At P1 and P5, AP-2a expression persists in nasal region
tissues, and becomes stronger in the metopic suture (Fig. 10D
and data not shown). In addition, h-galactosidase activity is
present in all suture junctions between the frontal bones and
the nasal, premaxillary, and maxillary bones. There is also
activity in the sutures separating the nasal and premaxillary
bones. Expression in the facial sutures is maintained in P10
skulls and continues through P15 (data not shown).
With respect to the tissues in which AP-2a may be
required, AP-2a expression and AP-2CRE/R26R h-galac-
tosidase activities coincide in the nasal bones, the fronto-
nasal, nasal, and metopic sutures (Figs. 11A,B), the nasal
cavity cartilage and conchae projections, and the mesen-
chyme of the vascular mucosa (Figs. 11E,F). Thus, we
would predict that the defects in the FKO mouse result from
the deletion of AP-2a in one or more of the above tissues.
Note that AP-2a is additionally expressed in the vessels of
the mucosa and within the frontal–premaxillary suture,
structures that do not possess AP-2CRE-mediated h-galac-
tosidase activity (Figs. 11A,B,E,F). Therefore, these tissues
are unlikely to be primary sites of the defects observed in
FKO snouts.Discussion
Conditional mutagenesis is a powerful approach to
address the roles of genes in specific tissues. The AP-
2CRE allele described in this study is an important tool
for understanding how a particular gene functions in a
subset of cranial neural crest and head mesenchyme tissues,
as well as within the distal limb structures. Use of this CRE
allele to eliminate AP-2a from the FNP generated a new
mouse model of midfacial hypoplasia, in which a unique
subset of craniofacial tissues is affected. In the FKO mice,
we hypothesize that the loss of AP-2a from these FNP
derivatives results in two ‘‘primary’’ defects that are respon-
sible for the mutant phenotypes. First, premature minerali-zation of the FKO nasal bone fronts inhibits growth at the
frontonasal suture junctions, ultimately truncating the mu-
tant facial complex. Second, the reductions in the FKO nasal
region vasculature likely account for the cartilage and bone
defects identified in the mutant nasal cavities.
Targeting CRE recombinase to the developing FNP and
limbs
To direct the expression of CRE recombinase to the
developing mouse FNP, we utilized a previously character-
ized human AP-2a FNP and limb mesenchyme enhancer
element (Zhang and Williams, 2003). AP-2CRE activity
begins between E8.75 and E9.0 in the lateral regions of the
head and migrating cranial neural crest, and it is robust in
the FNP proper from E9.5 onward. In the limbs, AP-2CRE-
mediated h-galactosidase activity is first detected around
E9.5, and is maintained in the distal two-thirds of the limb
bud and subsequent muscular and skeletal elements.
Derivatives of the embryonic FNP marked in AP-2CRE/
R26R skulls include the nasal bones, the facial and metopic
sutures, as well as the nasal cavity cartilage and mucosal
mesenchyme. It is interesting to note that h-galactosidase
activity is also observed in the frontal bones and the
premaxilla, in regions immediately adjacent to AP-2CRE-
positive sutures. Thus, the enzyme activities likely reflect
the nature of suture cell recruitment to the bone fronts for
membrane bone growth to occur. Importantly, the structures
marked by AP-2CRE are a specific subset of the cranial
neural crest derivatives identified in embryos and pups
containing Wnt1-Cre and R26R, in which the frontal bones,
the coronal sutures, and part of the sagittal sutures are also
positive (Jiang et al., 2002). Therefore, the AP-2CRE line is
a unique tool that will be extremely useful for loss of
function studies within craniofacial neural crest-derived
structures.
FKO snout truncation is due to impaired growth at the
frontonasal suture
Tissue-specific deletion of AP-2a was accomplished
using the AP-2CRE and Alflox conditional alleles, and the
resulting FKO embryos lack AP-2a expression in FNP and
limb bud mesenchyme. Unexpectedly, given the severe
craniofacial defects observed in previous AP-2a mutant
studies (Nottoli et al., 1998; Schorle et al., 1996; Zhang et
al., 1996), FKO embryos do not have obvious facial
anomalies. Rather, FKO pups display postnatal craniofacial
shortening and interorbital hypertelorism that are subtle at
P15, but become more obvious as the mice mature. Inter-
estingly, the FKO mice do not exhibit forelimb defects,
which illustrates that loss of AP-2a after E9.5 in the distal
mesenchyme is not sufficient to affect patterning in the
zeugopod. This latter observation indicates that AP-2a may
be required earlier in limb development, or perhaps within a
different tissue, such as the limb ectoderm.
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type mice is characterized by the outgrowth of the nasal and
premaxillary bones, coupled with an increasing complexity
of the interdigitation patterns within the frontonasal and
frontal-premaxillary sutures. In the FKO snouts, both the
nasal and frontal bones are truncated in their proximodistal
axes, and the nasal bones are visibly shorter than the
adjacent premaxillary bones. Several lines of evidence
support the conclusion that the lack of nasal and frontal
bone outgrowth in the mutants is primarily due to impaired
growth at the frontonasal suture caused by the absence of
AP-2a within this junction. First, the frontonasal sutures are
major sites of postnatal AP-2a expression, and the cells that
generate these structures are efficiently targeted by AP-
2CRE during embryogenesis (Figs. 11A,B). Second, in
contrast to wild-type samples, the FKO frontonasal sutures
do not become extensively interdigitated, and they exhibit a
posterior displacement with respect to the frontal-premaxil-
lary sutures (Figs. 11C,D). With respect to the cause of the
FKO frontonasal suture growth defects, sagittal sections
illustrate that the mutant nasal bone fronts are very similar
to those of wild-type samples through P10, but by P15 they
contain fewer undifferentiated, nonmineralized osteoblasts.
These characteristics are potentially caused by the premature
differentiation and subsequent mineralization of osteoblasts
within the proximal region of the FKO nasal bone fronts,
both of which are hallmarks of craniosynostosis disorders
(Fragale et al., 1999; Zhang et al., 2002). In contrast,
mineralization levels are comparable between wild-type
and FKO distal nasal bone sections, which indicates that
the mineralization defects in the mutants are specific to the
nasal bone fronts. It is important to note that additional
features of the FKO snouts can be attributed to a lack of
frontonasal suture growth. Without growth at suture junc-
tions, skull bones can increase in thickness but not in length
(Mao, 2002). In addition, studies have shown that physically
restraining the frontonasal suture results in nasal bone
truncation as well as shortening of the ethmoid structures
that underlie the nasal bones (Babler et al., 1987; Persing et
al., 1991). Taken together, these data indicate that growth
inhibition at the frontonasal suture could cause the increased
thickness of the mutant nasal bones, as well as the trunca-
tion of the entire craniofacial complex observed in FKO
snouts.
In both human and mouse, suture function has been
linked to the appropriate expression and activity of FGFR-
2, and many human craniosynostosis cases have been
associated with mutations in FGFR-2 that lead to aberrant
receptor activation (Reardon et al., 1994; Wilkie et al.,
1995; for reviews see Opperman, 2000; Ornitz and Marie,
2002; Wilkie and Morriss-Kay, 2001). FGFR-2 is expressed
in the osteogenic fronts of the membrane bones within the
developing skull, and its expression coincides with bone
front proliferation in E17.5 mouse embryos (Iseki et al.,
1997, 1999). A recent study in the mouse has recapitulated
human coronal suture synostosis by altering FGFR-2 ex-pression, through the elimination of the FGFR-2-IIIC iso-
form from the embryonic skeletogenic mesenchyme
(Eswarakumar et al., 2002). This defect is due to a loss
of proliferating cells in the frontal and parietal bone fronts,
which leads to reduced osteogenic potential and premature
differentiation (Eswarakumar et al., 2002). Given the con-
nection between FGFR-2 and synostosis, we examined
FGFR-2 expression in the relevant sutures of FKO and
wild-type skulls. In contrast to normal littermates, we detect
slightly weaker and variable FGFR-2 expression in the
mutants, but at early postnatal time points this did not
coincide with any significant difference in suture cell
proliferation. However, with PCNA staining at P15, we
were able to detect differences between wild-type and FKO
samples. In wild-type frontonasal sutures, the nasal bone
fronts are largely PCNA-positive, which likely reflects the
undifferentiated state of the cells. In contrast, the FKO nasal
bone fronts are mostly PCNA-negative, correlating with the
more differentiated nature of the mutant bone front. There-
fore, we postulate that in FKO embryos, there is a defect in
the establishment of critical bone fronts that ultimately
reduces the postnatal growth potential of the nasal bones.
Differential growth activity along the length of the fronto-
nasal suture may also explain the craniofacial defects seen
in a low percentage of heterozygous AP-2a-null mice
(Nottoli et al., 1998). In affected heterozygotes, we see a
curvature of the snout that results in misalignment of the
upper and lower incisors. In this instance, we hypothesize
that the reduced levels of AP-2a in the facial complex reach
a threshold at which the bone fronts may not function
effectively. If only one side of the frontonasal suture was
adversely affected, then the adjacent frontal and nasal bones
would be shorter, causing the snout to curve towards the
affected side.
In addition to defects within the frontonasal sutures, the
metopic sutures of FKO mice display ectopic interfrontal
(IF) bone. Because a substantial percentage of wild-type
samples also contain IF bone, and only mice with the FKO
genetic combination display snout truncations, there is not
an absolute causal relationship between the presence of the
ectopic bone and frontonasal suture defects. One potential
cause of the ectopic bone is the mixture of genetic back-
grounds that occurs in our breeding scheme. Strain mixing
has been associated with increasing the propensity of IF
bone in wild-type specimens (Fukuta et al., 1988), and each
allele required in our study was maintained within a
different strain of mouse. However, because of the 100%
penetrance of the IF bone in FKO samples, it is also possible
that the loss of AP-2a directly affects the metopic suture
mesenchyme by promoting osteogenesis. Such a conclusion
is supported by the observations that the mutant nasal bone
fronts also appear to be affected by inappropriate osteogenic
differentiation.
Finally, an intriguing field of suture biology is dedicated
to understanding how biomechanical forces contribute to
suture growth and interdigitation, and the subsequent lon-
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2002). For example, mice fed a granulated diet exhibit
reduced nasal bone lengths when compared to mice fed
on a solid diet, indicating that increased masticatory func-
tion promotes growth of the nasal bones (Kiliaridis et al.,
1985; Tokimasa et al., 2000). Studies have also shown that
application of exogenous oscillatory mechanical strain stim-
ulates osteogenic proliferation within the frontonasal sutures
(Mao et al., 2003). Together, the data show that suture
junctions are capable of responding to mechanical stimuli
by proliferating and differentiating, which subsequently
facilitates the elongation of adjacent bones. Because growth
is perturbed at the FKO frontonasal suture junctions, it is
interesting to consider that AP-2a might play a role in the
signaling pathways that communicate sutural mechanical
strain.
Vascular deficiency contributes to FKO nasal cavity
anomalies
Vascular defects were observed in FKO nasal bones, the
mucosa lining the nasal cavity, and the VNO. All mutants
processed between P10 and P15 display obvious reductions
in the sizes of the VNO vessels, and we speculate that some
degree of vascular dysfunction is present in all FKO pups.
Importantly, AP-2a is expressed throughout the mucosa and
blood vessels, while AP-2CRE activity is confined to the
mesenchyme surrounding the vessels (Figs. 11E,F). This
suggests that the vascular reductions in FKO snouts are due
to defects within the mucosal environment in which the
blood vessels develop.
We hypothesize that the abnormalities within the FKO
superior nasal conchae, septal cartilage, and olfactory
epithelium are secondary to the reduction in snout vascu-
lature as vascular defects are known to disrupt growth of
bone and cartilage (Gerber et al., 1999; Maes et al., 2002;
Zelzer et al., 2002, reviewed in Gerber and Ferrara, 2000).
With respect to the conchae, which ossify endochondrally,
the lack of growth may be attributed to defects in vascular
invasion that occur in the postnatal period. In contrast to
membranous and endochondral bones, cartilage is an avas-
cular tissue that relies on diffusion from adjacent blood
vessels for obtaining oxygen and subsequently removing
waste (Zelzer et al., 2002, reviewed in Blair et al., 2002).
Therefore, the mucosal vascular network likely supplies the
necessary oxygen required for the postnatal growth and
maintenance of the adjacent nasal septal cartilage. We
speculate that in the FKO mucosa, the reduced numbers
of vessels negatively affect the nearby cartilage by impair-
ing matrix secretion. It has been shown in vitro that
hypoxic conditions suppress the expression of the a subunit
of Type II collagen, a major component of the cartilage
matrix (Grimshaw and Mason, 2001). Of interest, the
intense toluidine blue stain observed in both wild-type
and FKO septal cartilage correlates with high levels of
Type II collagen expression, and is typical of proliferativechondrocytes (Naumann et al., 2002). In the FKO samples,
the regions that lack intense cartilage stain do contain cells
that resemble immature chondrocytes, and they are in
regions associated with reduced numbers of vessels. Thus,
in the FKO nasal cavity, hypoxic conditions may exist in
FKO snouts, which would suppress Type II collagen
expression in adjacent chondrocytes and lead to patches
of cells that are devoid of toluidine blue stain. Similar to the
septal cartilage, the olfactory epithelium is adjacent to and
likely relies upon the vascular mucosa for proper nourish-
ment and subsequent development. The defects within the
epithelial layers are truly secondary, as AP-2a and AP-
2CRE are not present in these tissues. The reductions in the
FKO olfactory epithelia also raise the intriguing possibility
that odor detection is impaired in the mutant mice. There-
fore, the FKO mouse mutant may be an interesting model
in which to study the influences of the vascular system
upon the postnatal development and function of the olfac-
tory system.
We cannot exclude the possibility that AP-2a may
directly regulate cartilage formation, as AP-2a expression
and AP-2CRE activity do coincide in the nasal septum and
superior conchae primordia in embryogenesis (see Figs.
11E,F). Therefore, AP-2a is lost from the cartilaginous
precursors of these structures in FKO snouts. However,
we do not favor this direct regulatory hypothesis for several
reasons. First, the expression of AP-2a in the cartilage and
the onset of the defects are inversely correlated. AP-2a
expression in these elements is greatest during embryogen-
esis and then becomes less robust as the mice mature. In
contrast, wild-type and FKO nasal conchae and septal
cartilage structures are indistinguishable through P5, the
defects in these structures appear around P10, and then
subsequently worsen as the mice mature. Second, the
cartilage defects are confined within the distal portions of
the nasal bones, regions in which the vasculature is most
noticeably reduced in FKO samples. Thus, these observa-
tions further support the notion that the hypoplasia of the
nasal septum and conchae result from reduced vascular
functions.
At this juncture, the possibility remains that reduced
vascular functions within the FKO snout contribute to the
frontonasal suture and/or nasal bone elongation defects.
However, our current hypothesis is that the vascular
reductions in FKO snouts do not impair growth of the
frontonasal suture. Rather, it is the loss of AP-2a from the
nasal bone fronts and associated suture tissues that results
in aberrant mineralization and growth inhibition of the
frontonasal junction. This conclusion is based on the
observations that AP-2a is robustly expressed in the nasal
bones and associated suture mesenchyme, and that the
snout vasculature within regions immediately adjacent to
the frontonasal sutures are similar in wild-type and FKO
samples. In contrast, the blood vessels within the distal
halves of the nasal bones are most compromised in the
mutants. In this study, we cannot yet distinguish whether
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of the nasal bone, or if nasal bone defects perturb vessel
growth. Experiments with additional CRE recombinase
lines specific for either bone or vasculature will be needed
to resolve these issues. Nevertheless, the vessel reductions
in the distal snout likely exacerbate the FKO nasal bone
truncation by reducing outgrowth potential. Finally, wheth-
er the lack of vasculature in the nasal cavity mucosa is a
direct result of the loss of AP-2a from the mucosal
mesenchyme, or results indirectly from defects in the
overlying nasal bones, the alteration in blood supply would
cause the defects found in septal cartilage and superior
nasal conchae projections.
In conclusion, the FKO mutants represent a new
mouse model of midfacial hypoplasia. Ultimately, deter-
mining how craniofacial outgrowth is compromised in the
FKO snouts at the cellular and molecular levels will
increase our comprehension of how facial tissues maintain
growth sites in the postnatal facial skeleton. Because a
variety of tissues are affected in these mutants, it will be
interesting to eliminate AP-2a from even more discrete
tissue or cell subtypes to determine where loss of the
gene is most detrimental to craniofacial development as
more CRE lines become available. Identification of the
specific cellular processes affected in the tissues that
require AP-2a will lead to a better understanding of
how this critical transcription factor functions in mamma-
lian development.Acknowledgments
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